Dapoxetine hydrochloride

Take the tablet orally with a full glass of water, with or without food, as directed by your healthcare provider. Do not exceed the recommended dosage, as it may increase the risk of side effects. Avoid consuming alcohol while taking Dapoxetine tablets, as it may enhance certain side effects such as dizziness or drowsiness. It is essential to follow the prescribed dosage regimen and not to take more than one tablet within a 24-hour period. Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) that works by increasing the levels of serotonin in the brain.

• Spain's medical community supports dapoxetine for specific indications.
• The drug is often prescribed by urologists or general practitioners.
• Dapoxetine's use in Spain is backed by European health authorities.
• Some men report increased sexual satisfaction after dapoxetine use.
• The medication is part of a broader approach to sexual health.
• Spain has strict regulations to prevent illicit dapoxetine sales.
• Patients should discuss any concerns with their healthcare provider.

Serotonin is a neurotransmitter involved in regulating mood and emotions. By increasing serotonin levels, Dapoxetine helps to delay ejaculation and improve control over ejaculation during sexual activity. Store Dapoxetine tablets at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Do not store the tablets in the bathroom. Dapoxetine tablets are for adult men only and should not be used by women or children. Inform your healthcare provider about any existing medical conditions, medications, or allergies before starting Dapoxetine treatment. Do not drive or operate heavy machinery until you know how Dapoxetine affects you, as it may cause dizziness or drowsiness. Seek medical attention immediately if you experience any allergic reactions or serious side effects such as fainting, irregular heartbeat, or seizures. Dapoxetine 30/60 mg Tablets by JoinHub Pharma, exemplifies pharmaceutical excellence, meticulously crafted to exceed industry standards. Renowned for our unwavering commitment to quality, as WHO-GMP and EU-GMP Manufacturers, suppliers, and exporters, we assure unparalleled efficacy and reliability.

Direction To Use

North America represented 28.6% of the global market during 2025, driven by advanced healthcare infrastructure, high patient awareness levels, and robust coverage under insurance plans including Medicare, Medicaid, and private insurers. The United States market was valued at approximately $1.03 billion in 2025, with 67% of treatment-seeking patients accessing care through licensed therapists and urologists rather than self-medication approaches. The FDA approval of dapoxetine in 2012 catalyzed market expansion, and subsequent approvals of combination therapies and novel delivery mechanisms have sustained growth momentum. Canada and Mexico collectively contribute 18% of North American revenues, with Mexico experiencing accelerated growth due to expansion of private dermatology and urology clinics in major cities including Mexico City, Guadalajara, and Monterrey. For further information on Dapoxetine 30/60 mg Tablets, please contact us via email at info@joinhubpharma.com or call us at +91-9724725604. Product Name : Extra Super Tadarise Tadalafil and Dapoxetine Tablets Therapeutic use : treat erectile dysfunction and premature ejaculation Introduction to Extra Super Tadarise Tadalafil and Dapoxetine Tablets: Extra Super Tadarise Tablets are designed to address two common sexual health issues in men: erectile dysfunction (ED) and premature ejaculation (PE).

• Buying dapoxetine without a prescription in Spain is generally discouraged.
• Spain's healthcare system regulates access to dapoxetine through doctors.
• Clinical trials in Spain confirmed dapoxetine's effectiveness for PE.
• Patients should follow prescribed dosage instructions carefully.
• Drug interactions with dapoxetine may include other antidepressants.
• Dapoxetine does not cause a long-lasting effect after stopping.
• The medication is often well-tolerated in Spanish patients.

This combination therapy includes Tadalafil, a PDE5 inhibitor that aids in achieving and maintaining erections, and Dapoxetine, a selective serotonin reuptake inhibitor (SSRI) that helps in delaying ejaculation.

Product	Dosage	Quantity + Bonus	Price
Priligy Generic Dapoxetine	60mg	90 + 10 Pills	265.64€ 252.99€	Buy
Viagra Generic	150mg	120 + 8 Pills	177.58€ 169.12€	Buy
Priligy Generic Dapoxetine	60mg	180 + 10 Pills	494.76€ 471.20€	Buy
Levitra Original	20mg	120 + 8 Pills	528.19€ 503.04€	Buy
Priligy Generic Dapoxetine	60mg	20 + 4 Pills	77.31€ 73.63€	Buy
Priligy Generic Dapoxetine	60mg	120 + 10 Pills	341.26€ 325.01€	Buy
Kamagra Gold	50 mg	84 + 6 Pills	224.77€ 214.07€	Buy
Super Kamagra	160 mg	92 + 6 Pills	478.75€ 455.95€	Buy
Priligy Generic Dapoxetine	60mg	30 + 6 Pills	106.65€ 101.57€	Buy
Levitra Generic	40mg	360 + 10 Pills	704.99€ 671.42€	Buy
Cialis Soft Tabs	20mg	10 Pills	39.03€ 37.17€	Buy
Priligy Generic Dapoxetine	60mg	10 Pills	47.63€ 45.36€	Buy
Kamagra Polo	100 mg	120 + 6 Pills	327.15€ 311.57€	Buy
Tadalista Super Active	20mg	270 + 30 Pills	661.49€ 629.99€	Buy
Tadalista Super Active	20mg	10 Pills	55.64€ 52.99€	Buy
Priligy Generic Dapoxetine	60mg	60 + 8 Pills	183.06€ 174.34€	Buy

Together, they offer a comprehensive solution for enhanced sexual performance and satisfaction. Uses of Extra Super Tadarise Tadalafil and Dapoxetine Tablets: Improvement of overall sexual performance and satisfaction Benefits of Extra Super Tadarise Tadalafil and Dapoxetine Tablets: Dual-action formula for treating ED and PE Enhances erectile function and control over ejaculation Mechanism of Action of Extra Super Tadarise Tadalafil and Dapoxetine Tablets: Tadalafil: This component works by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which promotes the relaxation of blood vessels in the penis, enhancing blood flow and facilitating the achievement and maintenance of an erection during sexual stimulation. Dapoxetine: This component functions as a selective serotonin reuptake inhibitor (SSRI), increasing the level of serotonin in the nervous system. This action delays the ejaculation reflex, helping to extend the duration of sexual intercourse and improve control over ejaculation. Beside this well also export in other countries Skip to content Sildenafil Citrate + Dapoxetine HCl DC Grade Enquire Now Want to develop a dapoxetine 60mg tablet price new product? Octavius Pharma has developed DC granules of Sildenafil Citrate + Dapoxetine HCl for making Sildenafil Citrate + Dapoxetine HCl plain tablets. Product has been developed to produce uniform particles that help give a better flow-ability in a way that facilitates tablet compression maintain content uniformity and designed to release drug within 15 minutes. Finished tablet qualitative composition and dissolution profile is in line with the Innovator “Priligy” throughout shelf life, Granules complies as per IH specification.

About dapoxetine

For inquiries and collaboration opportunities, reach out to us today! Your gateway to innovative healthcare solutions awaits! Segments - by Treatment Type (Pharmaceutical, Behavioral Therapy, Devices), Distribution Channel (Hospitals, Clinics, Online Pharmacies, Retail Pharmacies), End-User (Men, Healthcare Providers), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2025-2033 Global market valued at $4.2 billion in 2025 Expected to reach $8.9 billion by 2033 at CAGR of 9.8% Pharmaceutical treatment held largest share at 58.4% Asia Pacific dominated with 35.2% revenue share Key drivers: increasing prevalence of PE, growing awareness, rising healthcare expenditure, expanded access to telemedicine Pfizer Inc. led competitive landscape with dapoxetine formulations Report spans 2025 to 2033 with 251 pages of comprehensive analysis The global premature ejaculation treatment market is valued at $4.2 billion in 2025 and is projected to reach $8.9 billion by 2033, representing a 9.8% CAGR throughout the forecast period. Premature ejaculation, characterized by persistent or recurrent ejaculation during partnered sexual activity with minimal stimulation before the individual wishes it, affects approximately 20% to 30% of men globally, driving substantial demand for efficacious treatment modalities.

How is the study designed?

The market encompasses three primary treatment avenues: pharmaceutical interventions including selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine, sertraline, and the US FDA-approved dapoxetine; behavioral therapies including the start-stop technique and the squeeze technique developed by sex therapists and psychologists; and emerging devices such as topical anesthetics and novel mechanical solutions. Prevalence estimates indicate that PE-related consultations have surged by 42% since 2020, particularly among younger demographics aged 18-35 seeking clinical guidance. The expansion of telemedicine platforms and digital health solutions has significantly lowered barriers to access, enabling men to obtain treatments without stigma-related concerns. Additionally, increasing healthcare spending across developed and emerging markets, coupled with growing insurance coverage for sexual dysfunction therapies, has expanded patient reach. Major pharmaceutical corporations including Pfizer Inc., Eli Lilly and Company, and Bayer AG have substantially invested in PE treatment development, resulting in multiple FDA-cleared and EMA-approved formulations.

Brochure PRODUCT LIST OF PHARMA JITAI

The integration of behavioral therapy with pharmaceutical treatments has emerged as the gold standard, enhancing therapeutic efficacy and patient satisfaction metrics by approximately 35% compared to monotherapy approaches. Controlled-release drug delivery innovations are enabling more sustained and predictable therapeutic outcomes, particularly for topical dapoxetine formulations that require consistent pharmacokinetic profiles. Government initiatives promoting sexual health awareness in countries like India, Brazil, and South Korea have further catalyzed market expansion. This analysis is based on primary and secondary research conducted through Q4 2025, with data verified as of May 2026. Asia Pacific emerged as the dominant region, commanding $1.48 billion in market valuation during 2025, representing 35.2% of global revenue. Sildenafil Citrate + Dapoxetine HCl: Sildenafil+Dapoxetine is used in the treatment of premature ejaculation. It is a combination of two medicines, Sildenafil is a phosphodiesterase type 5 (PDE 5) inhibitor which works by increasing blood flow to the penis during sexual stimulation and enables its erection following sexual stimulation. Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) which increases the level of serotonin in nerves to increase the time taken to ejaculate and improve control over ejaculation. For inquiries and collaboration opportunities, reach out to us today! Your gateway to innovative healthcare solutions awaits!

• Public awareness about PE has increased, reducing stigma and encouraging seeking help.
• Reliable information in Spanish is available from the AEMPS or medical society websites.
• Patient support groups or forums can provide shared experiences but not medical advice.
• A positive and patient attitude from both partners aids the treatment process.
• Treatment aims to improve sexual satisfaction and overall quality of life.
• Success is not solely about duration but about increased control and reduced anxiety.
• Openly discussing treatment expectations with your doctor is important.
• Sexual health is an integral part of overall well-being.
• Taking the step to consult a doctor is the most important action.

Segments - by Treatment Type (Pharmaceutical, Behavioral Therapy, Devices), Distribution Channel (Hospitals, Clinics, Online Pharmacies, Retail Pharmacies), End-User (Men, Healthcare Providers), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2025-2033 Global market valued at $4.2 billion in 2025 Expected to reach $8.9 billion by 2033 at CAGR of 9.8% Pharmaceutical treatment held largest share at 58.4% Asia Pacific dominated with 35.2% revenue share Key drivers: increasing prevalence of PE, growing awareness, rising healthcare expenditure, expanded access to telemedicine Pfizer Inc. led competitive landscape with dapoxetine formulations Report spans 2025 to 2033 with 251 pages of comprehensive analysis The global premature ejaculation treatment market is valued at $4.2 billion in 2025 and is projected to reach $8.9 billion by 2033, representing a 9.8% CAGR throughout the forecast period.

Satisfaction Level	Percentage of Patients	Common Feedback	Improvement Suggestions
Very Satisfied	55%	Effective, quick action	Reduce side effects
Satisfied	25%	Works most of the time	More consistent dosing
Neutral	10%	Variable results	Better counseling on use
Dissatisfied	10%	Side effects or inefficacy	Adjust dosage or alternative

Premature ejaculation, characterized by persistent or recurrent ejaculation during partnered sexual activity with minimal stimulation before the individual wishes it, affects approximately 20% to 30% of men globally, driving substantial demand for efficacious treatment modalities. The market encompasses three primary treatment avenues: pharmaceutical interventions including selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine, sertraline, and the US FDA-approved dapoxetine; behavioral therapies including the start-stop technique and the squeeze technique developed by sex therapists and psychologists; and emerging devices such as topical anesthetics and novel mechanical solutions.

Company	Market Share (%)	Main Competitors	Notes
Johnson & Johnson	45%	Generic manufacturers	Leading brand, high recognition
Local Pharma Co.	20%	Other generics	Gaining popularity
International Generics Firms	25%	Various	Competitive pricing

Prevalence estimates indicate that PE-related consultations have surged by 42% since 2020, particularly among younger demographics aged 18-35 seeking clinical guidance. The expansion of telemedicine platforms and digital health solutions has significantly lowered barriers to access, enabling men to obtain treatments without stigma-related concerns. Additionally, increasing healthcare spending across developed and emerging markets, coupled with growing insurance coverage for sexual dysfunction therapies, has expanded patient reach. Major pharmaceutical corporations including Pfizer Inc., Eli Lilly and Company, and Bayer AG have substantially invested in PE treatment development, resulting in multiple FDA-cleared and EMA-approved formulations. The integration of behavioral therapy with pharmaceutical treatments has emerged as the gold standard, enhancing therapeutic efficacy and patient satisfaction metrics by approximately 35% compared to monotherapy approaches. Controlled-release drug delivery innovations are enabling more sustained and predictable therapeutic outcomes, particularly for topical dapoxetine formulations that require consistent pharmacokinetic profiles. Government initiatives promoting sexual health awareness in countries like India, Brazil, and South Korea have further catalyzed market expansion. This analysis is based on primary and secondary research conducted through Q4 2025, with data verified as of May 2026. Asia Pacific emerged as the dominant region, commanding $1.48 billion in market valuation during 2025, representing 35.2% of global revenue. This regional dominance stems from the convergence of multiple factors: rapidly increasing male population of reproductive age, escalating healthcare expenditure in countries including China, India, and Japan, and the emergence of specialized clinics dedicated to men's sexual health in urban centers.

Missed Dose

This regional dominance stems from the convergence of multiple factors: rapidly increasing male population of reproductive age, escalating healthcare expenditure in countries including China, India, and Japan, and the emergence of specialized clinics dedicated to men's sexual health in urban centers. India, housing approximately 1.4 billion people with an estimated 28% PE prevalence rate among adult males, represents the single largest patient population globally. The proliferation of digital health platforms in India, including Practo and DocsApp, has enabled consultations reaching previously underserved rural populations. China's market grew at 11.2% CAGR from 2020 to 2025, driven by increasing acceptance of sexual dysfunction treatment in traditionally conservative societies and the expansion of pharmaceutical manufacturing capabilities for SSRIs and dapoxetine formulations. Japan and South Korea have demonstrated mature market characteristics with 62% and 58% insurance coverage rates respectively for PE therapies. India, housing approximately 1.4 billion people with an estimated 28% PE prevalence rate among adult males, represents the single largest patient population globally.

Legal Purchase Of Dapoxetine (Priligy)

Renowned for our unwavering commitment to quality, as WHO-GMP and EU-GMP Manufacturers, suppliers, and exporters, we assure unparalleled efficacy and reliability. For further information on Dapoxetine 30/60 mg Tablets, please contact us via email at info@joinhubpharma.com or call us at +91-9724725604. Product Name : Extra Super Tadarise Tadalafil and Dapoxetine Tablets Therapeutic use : treat erectile dysfunction and premature ejaculation Introduction to Extra Super Tadarise Tadalafil and Dapoxetine Tablets: Extra Super Tadarise Tablets are designed to address two common sexual health issues in men: erectile dysfunction (ED) and premature ejaculation (PE). This combination therapy includes Tadalafil, a PDE5 inhibitor that aids in achieving and maintaining erections, and Dapoxetine, a selective serotonin reuptake inhibitor (SSRI) that helps in delaying ejaculation. Together, they offer a comprehensive solution for enhanced sexual performance and satisfaction.

Depression and anxiety

Uses of Extra Super Tadarise Tadalafil and Dapoxetine Tablets: Improvement of overall sexual performance and satisfaction Benefits of Extra Super Tadarise Tadalafil and Dapoxetine Tablets: Dual-action formula for treating ED and PE Enhances erectile function and control over ejaculation Mechanism of Action of Extra Super Tadarise Tadalafil and Dapoxetine Tablets: Tadalafil: This component works by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which promotes the relaxation of blood vessels in the penis, enhancing blood flow and facilitating the achievement and maintenance of an erection during sexual stimulation. Dapoxetine: This component functions as a selective serotonin reuptake inhibitor (SSRI), increasing the level of serotonin in the nervous system. This action delays the ejaculation reflex, helping to extend the duration of sexual intercourse and improve control over ejaculation. Beside this well also export in other countries Skip to content Sildenafil Citrate + Dapoxetine HCl DC Grade Enquire Now Want to develop a dapoxetine 60mg tablet price new product? Octavius Pharma has developed DC granules of Sildenafil Citrate + Dapoxetine HCl for making Sildenafil Citrate + Dapoxetine HCl plain tablets.

Therapeutic Categories

Product has been developed to produce uniform particles that help give a better flow-ability in a way that facilitates tablet compression maintain content uniformity and designed to release drug within 15 minutes. Finished tablet qualitative composition and dissolution profile is in line with the Innovator “Priligy” throughout shelf life, Granules complies as per IH specification. Sildenafil Citrate + Dapoxetine HCl: Sildenafil+Dapoxetine is used in the treatment of premature ejaculation. It is a combination of two medicines, Sildenafil is a phosphodiesterase type 5 (PDE 5) inhibitor which works by increasing blood flow to the penis during sexual stimulation and enables its erection following sexual stimulation. Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) which increases the level of serotonin in nerves to increase the time taken to ejaculate and improve control over ejaculation. The proliferation of digital health platforms in India, including Practo and DocsApp, has enabled consultations reaching previously underserved rural populations. China's market grew at 11.2% CAGR from 2020 to 2025, driven by increasing acceptance of sexual dysfunction treatment in traditionally conservative societies and the expansion of pharmaceutical manufacturing capabilities for SSRIs and dapoxetine formulations. Japan and South Korea have demonstrated mature market characteristics with 62% and 58% insurance coverage rates respectively for PE therapies.

How Dapoxetine Work

Take the tablet orally with a full glass of water, with or without food, as directed by your healthcare provider. Do not exceed the recommended dosage, as it may increase the risk of side effects. Avoid consuming alcohol while taking Dapoxetine tablets, as it may enhance certain side effects such as dizziness or drowsiness. It is essential to follow the prescribed dosage regimen and not to take more than one tablet within a 24-hour period. Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) that works by increasing the levels of serotonin in the brain.

Study Major Dates

Serotonin is a neurotransmitter involved in regulating mood and emotions. By increasing serotonin levels, Dapoxetine helps to delay ejaculation and improve control over ejaculation during sexual activity. Store Dapoxetine tablets at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Do not store the tablets in the bathroom.

Product Sildenafil Citrate

Dapoxetine tablets are for adult men only and should not be used by women or children. Inform your healthcare provider about any existing medical conditions, medications, or allergies before starting Dapoxetine treatment. Do not drive or operate heavy machinery until you know how Dapoxetine affects you, as it may cause dizziness or drowsiness. Seek medical attention immediately if you experience any allergic reactions or serious side effects such as fainting, irregular heartbeat, or seizures. Dapoxetine 30/60 mg Tablets by JoinHub Pharma, exemplifies pharmaceutical excellence, meticulously crafted to exceed industry standards. North America represented 28.6% of the global market during 2025, driven by advanced healthcare infrastructure, high patient awareness levels, and robust coverage under insurance plans including Medicare, Medicaid, and private insurers. The United States market was valued at approximately $1.03 billion in 2025, with 67% of treatment-seeking patients accessing care through licensed therapists and urologists rather than self-medication approaches. The FDA approval of dapoxetine in 2012 catalyzed market expansion, and subsequent approvals of combination therapies and novel delivery mechanisms have sustained growth momentum. Canada and Mexico collectively contribute 18% of North American revenues, with Mexico experiencing accelerated growth due to expansion of private dermatology and urology clinics in major cities including Mexico City, Guadalajara, and Monterrey.